# Nunaps

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nunaps

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: www.nunaps.co.kr/
- Total disclosed funding: $13M
- Latest round: Series B (Jan 14, 2025)
- Investors on record: 7

## About

Founded in 2017 and based in Seoul, South Korea, Nunaps Inc. is a digital therapeutics company that develops a virtual reality device designed to assist visually impaired patients. The company's platform operates Nunap Vision, a solution that provides visual perceptual training to treat visual field defects caused by brain damage.

## Funding rounds

- Series B, Jan 14, 2025, $8.9M — Korea Development Bank, WOORI Venture Partners, Smilegate Investment, Company K Partners, Hanwha Investment & Securities, Tomato System Co., Ltd.
- Series A, Dec 3, 2019, $4.2M — WOORI Venture Partners, Company K Partners, K2 Investment Partners

## Investors

- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series A, Series B
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series A, Series B
- K2 Investment Partners (https://capitalatlas.ai/funds/k2-investment-partners) — Series A
- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series B
- Smilegate Investment (https://capitalatlas.ai/funds/smilegate-investment) — Series B
- Hanwha Investment & Securities (https://capitalatlas.ai/funds/hanwha-investment-securities) — Series B
- Tomato System Co., Ltd. — Series B